Feedback / Questions
liraltagene autoleucel (lira-cel) - Anixa Biosci, Moffitt Cancer Center
https://www.prnewswire.com/news-releases/anixa-biosciences-reports-updated-positive-survival-observations-from-ongoing-phase-1-trial-of-lira-cel-ovarian-cancer-car-t-therapy-302767413.html
May 11, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next